Keyphrases
Type 1 Diabetes Mellitus (T1DM)
100%
Type I Diabetes
100%
Hypoglycemia
99%
Counterregulatory Response
56%
Hemoglobin A1c (HbA1c)
33%
C-peptide
32%
Asymptomatic Hypoglycemia
29%
Co-therapy
29%
COVID-19
27%
Placebo
26%
Glycemic Control
26%
Adjunct Therapy
26%
Meta-analysis
26%
Non-insulin
26%
Modern Technologies
26%
Therapeutic Strategies
26%
Physical Exercise
26%
Systematic Meta-analysis
26%
Insulin Resistance
26%
Cardiovascular Pathophysiology
26%
Saxagliptin
26%
Vitamin D Supplementation
26%
Pharmacologic Interventions
26%
Fasting Plasma Glucose
26%
Healthcare Professionals
26%
Pregnancy Outcome
26%
Gestational Diabetes
26%
Interview Study
26%
Diazoxide
26%
Multicenter Retrospective Cohort Study
26%
Healthcare Management
26%
Health Technology
26%
Coronavirus Disease (COVID)
26%
Patient Care
26%
Pre-existing Diabetes
26%
Self-management
26%
Gestational Diabetes Mellitus
26%
Virtual Care
26%
Cardiovascular System
26%
Hypoglycemia Unawareness
24%
Vitamin D
21%
Glycaemia
21%
Marathon
17%
KATP Channel
15%
Glucose Variability
14%
Patients with Diabetes
13%
Total Blood Volume
13%
Neonatal Unit Admission
13%
GDM Risk
13%
Pressure-volume
13%
Medicine and Dentistry
Insulin Dependent Diabetes Mellitus
81%
Hypoglycemia
78%
Gestational Diabetes
52%
Diabetes
47%
C-Peptide
37%
Hemoglobin A1c
34%
Placebo
33%
Health Care Management
26%
Adjuvant Therapy
26%
Supplementation
26%
Systematic Review
26%
Meta-Analysis
26%
Retrospective Cohort Study
26%
Insulin Resistance
26%
Health Care
26%
Saxagliptin
26%
Vitamin D
26%
Glycemic Control
26%
Diazoxide
26%
COVID-19
15%
Adenosine Triphosphate Sensitive Potassium Channel
15%
Awareness
13%
Childbirth
13%
Emergency Care
13%
Body Mass Index
13%
Large for Gestational Age
13%
Oral Glucose Tolerance Test
13%
Screening
13%
Care Pathway
13%
Prevalence
13%
First Trimester Pregnancy
13%
Patient with Diabetes
13%
National Health Service
13%
Perinatal Mortality
13%
Diagnostic Procedure
13%
Diagnosis
13%
Impaired Glucose Tolerance
8%
Experimental Hypoglycemia
8%
Dipeptidyl Peptidase IV
8%
Epinephrine
8%
Randomized Controlled Trial
7%
Insulin Treatment
6%
Glycemic
5%